Abstract:Quadrupolar NMR crystallography guided crystal structure prediction (QNMRX-CSP) is a nascent protocol for predicting, solving, and refining crystal structures. QNMRX-CSP employs a combination of solid-state NMR data from quadrupolar nuclides ( i.e. , nuclear spin > 1/2), static lattice energies and electric field gradient (EFG) tensors from dispersion-corrected density functional theory (DFT-D2*) calculations, and powder X-ray diffraction (PXRD) data; however, it has so far been applied only to organic HCl salts with small and rigid organic components, using 35 Cl EFG tensor data for both structural refinement and validation. Herein, the QNMRX-CSP protocol is extended to ephedrine HCl (Eph) and pseudoephedrine HCl (Pse), which are diastereomeric compounds that feature distinct space groups and organic components that are larger and more flexible. A series of benchmarking calculations are used to generate structural models that can be validated against experimental data, and to explore the impacts of the (i) starting structural models ( i.e. , geometry-optimized fragments based on either a known crystal structure or an isolated gas-phase molecule) and (ii) selection of unit cell parameters and space groups. Finally, we use QNMRX-CSP to predict the structure of Pse in the dosage form Sudafed using only 35 Cl SSNMR data as experimental input. This proof-of-concept work suggests the possibility of employing QNMRX-CSP protocols to solve the structures of organic HCl salts in dosage forms – something which is often beyond the capabilities of conventional, diffraction-based characterization methods.
What problem does this paper attempt to address?
The paper primarily focuses on expanding and validating a method known as QNMRX-CSP (Quadrupolar Nuclei Magnetic Resonance Crystallography-guided Crystal Structure Prediction) to address the crystal structure prediction issues of organic salt drugs in practical applications, especially for those large molecules, highly flexible, and multi-component systems that are difficult to resolve using traditional diffraction methods.
Specifically, the paper begins by reviewing the development of Crystal Structure Prediction (CSP) methods and their applications in new drug development, metal-organic frameworks, and organic semiconductors. It points out the challenges faced by CSP methods, including the need for search algorithms for complex structural spaces and the accurate ranking of relative energies of candidate structures.
Subsequently, the paper introduces the extensive application of NMR Crystallography (NMRX) combined with Solid-State NMR (SSNMR), quantum chemical calculations, and Powder X-ray Diffraction (PXRD) data in structure prediction, refinement, and validation, emphasizing its importance in improving CSP methods. In particular, in utilizing the NMR signals of quadrupolar nuclei (such as chlorine-35), although such nuclei are commonly present in organic solids, their application in CSP research is not yet sufficient, partly due to the technical difficulties in obtaining high-quality SSNMR spectra and the issues with matching computed Electric Field Gradient (EFG) tensors with experimental data.
To overcome these limitations, the authors' team developed a QNMRX-CSP protocol that predicts, validates, and refines the crystal structures of organic salt drugs by comparing the experimental and computed chlorine-35 EFG tensors. This method has been validated in the prediction of small molecule simple organic salts, and the next goal is to apply it to larger, more complex organic molecules, such as ephedrine hydrochloride (Eph) and pseudoephedrine hydrochloride (Pse), which have different space groups and larger molecular sizes.
The paper details the four key steps of the QNMRX-CSP protocol: 1) generating initial structural models; 2) optimizing structures through DFT-D2* calculations; 3) comparing experimental and computed 35Cl EFG tensors to filter structures that match experimental data; 4) further validating candidate structures using PXRD data.
Furthermore, the paper explores the potential application of the QNMRX-CSP method in actual pharmaceutical formulations, such as predicting the crystal structure of pseudoephedrine in Sudafed formulations using only 35Cl SSNMR data, demonstrating the method's potential value in addressing microcrystalline drug structural changes.
Finally, the paper discusses the future development directions of the QNMRX-CSP method, including incorporating information from other quadrupolar nuclei (such as nitrogen-14, oxygen-17) and the synergistic effect with conventional NMRX-CSP methods. This will enable the method to be applied to larger, more complex molecular systems, thereby broadening its application scope in drug development.